Ibex Medical Analytics Announces Expansion of its Biopharma Business, Extending AI Pathology Platform into Early Biomarker Development

BOSTON--(BUSINESS WIRE)--Jan 6, 2026--

Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced a significant expansion of its biopharma business. Building on its successful collaborations in late-stage biomarker development, Ibex is now extending its platform into earlier translational research, biomarker development, and trial-efficiency optimization.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106469089/en/

Ibex’s high-performance AI platform—already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche —now supports exploratory, preclinical, and clinical evidence generation, while providing a seamless foundation for future companion diagnostic (CDx) programs.

"In an era where modalities like antibody-drug conjugates (ADC), immune-modulating agents, and molecularly guided therapies are reshaping oncology, the field needs biomarkers that match the complexity of our treatments and enable adequate patient selection”, says Paolo Tarantino, M.D., Research and Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School. “AI-based biomarker platforms can integrate multiple dimensions of cancer biology in a rapid, objective, and reliable way, offering a terrific opportunity to enhance treatment tailoring. This platform has the potential to transform both early and late drug development, further accelerating drug development and ensuring precision in oncology."

New Analytical Modules

Ibex will be introducing new and expanded AI modules relevant to high-priority therapeutic areas, such as:

These modules are developed under ISO 13485-aligned design control, in an IVD-ready architecture, and supported by fully versioned pipelines and audit trails that meet global regulatory expectations.

“Pharma needs partners that can support biomarker innovation from the earliest exploratory work to fully regulated CDx programs. With our proven execution in late-stage development including FDA and CE-IVDR clearances, and as we strengthen our translational capabilities, we are uniquely positioned to accelerate drug development pipelines and improve evidence quality worldwide,” remarks Joseph Mossel, Co-Founder & CEO, Ibex Medical Analytics.

A Platform Built for Security, Scale, and Global Deployment

With next-generation enterprise security, validated through detailed big-pharma due diligence—including IT security, supplier risk, and privacy assessments, the system can be deployed in dedicated virtual private clouds, on-prem, hybrid, or air-gapped environments and is compatible with leading WSI scanners, DICOM-DP infrastructure, HL7/FHIR workflows, and structured outputs for regulated trial endpoints.

Learn more at: https://ibex-ai.com/biopharma/

About Ibex Medical Analytics

Ibex is a global leader in clinical-grade AI for pathology, with deployed solutions in over 50 health systems and partnerships spanning life-science companies, reference laboratories, and digital pathology vendors. Ibex’s platform supports biomarker discovery, clinical trial efficiency, and CDx-ready evidence generation, backed by an ISO 13485-compliant QMS.

The Ibex platform includes solutions that are CE-IVD certified and registered with the UK MHRA, TGA in Australia and ANVISA in Brazil. It includes a solution that is FDA cleared and others that are Research Use Only (RUO) in the United States.

Ibex's platform now extends to earlier translational research, biomarker development, and trial-efficiency optimization

KAMPALA, Uganda (AP) — Ugandan opposition leader Bobi Wine said on Saturday he fled the country to escape a military search for him in the aftermath of a disputed presidential election.

Wine, whose real name is Kyagulanyi Ssentamu, went into hiding shortly after the Jan. 15 presidential election. Ugandan President Yoweri Museveni won the election with 71.6% of the vote, according to official results that Wine rejects as fake.

Wine’s location has been unknown to the general public for weeks, with growing concern for his safety after the army chief, Gen. Muhoozi Kainerugaba, repeatedly posted threats against him on social platform X.

Kainerugaba, the president’s son and presumptive heir, has suggested Wine is wanted for unspecified crimes. Ugandan police say they are not looking for him.

In a video message posted on X on Saturday, an unshaven Wine said he managed to leave Uganda but did not reveal where he went.

“Fellow Ugandans and friends of Uganda all over the world, by the time you see this video I will have left the country for some critical engagements outside Uganda,” he said. “And at the right time I will come back and continue with the cause. I thank all of you fellow Ugandans who have concealed and protected me for all this time when the regime was looking for me.”

He said it was impossible for Ugandan security operatives to find him “because the people have protected me.”

Ugandan soldiers raided Wine’s house the day after the Jan. 15 vote, but the opposition leader had already gone into hiding, fearing for his life after campaigning for weeks in helmet and flak jacket at rallies where security forces were a constant presence.

The hunt for Wine is being led by Kainerugaba, who has called Wine a “baboon” and a “terrorist.” Kainerugaba has a yearslong habit of posting offensive tweets, which he often deletes later.

Wine, the most prominent of seven candidates who ran against Museveni, has a large following among young people in urban areas, many of them unemployed or angry with the government over official corruption and the lack of economic opportunities. Many want to see political change after four decades of the same leader.

In May, the 81-year-old Museveni will be sworn in for a seventh term that would bring him closer to five decades in power.

His supporters credit him for the relative peace and stability that has made Uganda home to hundreds of thousands fleeing violence elsewhere in this part of Africa. But opposition figures, including some who previously were his close allies, condemn what they see as a descent into authoritarianism.

FILE - Uganda opposition presidential candidate Robert Kyagulanyi Ssentamu who is known as Bobi Wine waves to supporters at an election campaign rally in Mukono, Uganda, Friday, Jan. 9, 2026. (AP Photo/Hajarah Nalwadda, File)